ASCO Updates ESA Treatment Guidelines
This article was originally published in The Pink Sheet Daily
Executive Summary
Recommendation made jointly with American Society of Hematology calls for maintaining hemoglobin levels above 10 g/dL.
You may also be interested in...
Requests To Reopen Medicare ESA Policy Are Not Yet Persuasive To CMS
Agency advises stakeholders that they must present new data or analysis that current data was materially misinterpreted in order to gain a reconsideration of the erythropoeisis-stimulating agents coverage policy.
Medicare EPO Proposal Would Withdraw Or Limit Coverage For Certain Cancer Uses
National Medicare coverage analysis follows recent FDA advisory committee review.
EPO Aggressive Dosing May Be Curtailed By New Black Box Warning
Labeling for Amgen’s Aranesp and Epogen and Johnson & Johnson’s Procrit updated March 9 to include a black box warning on risk of mortality.